Literature DB >> 9213344

Disc susceptibility testing for thermomphilic campylobacters.

M B Huysmans1, J D Turnidge.   

Abstract

The minimum inhibitory concentrations (MICs) and zone diameters around NCCLS strength discs of 100 clinical isolates of thermophilic Campylobacter species, including 79 strains of Campylobacter jejuni subsp. jejuni, 19 of C. coli and two of C. lari, plus three type strains of these species, were determined for erythromycin, clindamycin, nalidixic acid, norfloxacin, ciprofloxacin, ampicillin, piperacillin, cephalothin, ceftriaxone, chloramphenicol, gentamicin and tetracycline. Using error-rate bounded analysis and adjustment of MIC breakpoints to fit natural populations, tentative interpretive zone diameter criteria were set for each of the antimicrobials. Application of these criteria showed that resistance to quinolones was not detected in species other than C. lari. Two strains of C. jejuni subsp. jejuni were susceptible to cephalothin. The type strain of C. lari was susceptible to erythromycin and resistant to clindamycin. Full resistance to erythromycin, chloramphenicol or gentamicin was not found in any strain, while nine strains were resistant to tetracycline. This disc method should provide a simple approach to resistance detection for surveillance or routine testing of invasive isolates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213344     DOI: 10.1080/00313029700169884

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods.

Authors:  Taradon Luangtongkum; Teresa Y Morishita; Amna B El-Tayeb; Aaron J Ison; Qijing Zhang
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

2.  PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003.

Authors:  Oralak Serichantalergs; Piyarat Pootong; Anders Dalsgaard; Ladaporn Bodhidatta; Patricia Guerry; David R Tribble; Sinn Anuras; Carl J Mason
Journal:  Gut Pathog       Date:  2010-11-10       Impact factor: 4.181

3.  Fluoroquinolone resistance in Campylobacter absent from isolates, Australia.

Authors:  Leanne Unicomb; John Ferguson; Thomas V Riley; Peter Collignon
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

Review 4.  Antimicrobial resistance mechanisms among Campylobacter.

Authors:  Kinga Wieczorek; Jacek Osek
Journal:  Biomed Res Int       Date:  2013-06-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.